MICS: gauge width impacts wound

Article

Gauges and knives used during microincision cataract surgery (MICS) should be of equal thickness, according to a study published in the July 2008 issue of the Journal of Cataract & Refractive Surgery.

Gauges and knives used during microincision cataract surgery (MICS) should be of equal thickness, according to a study published in the July 2008 issue of the Journal of Cataract & Refractive Surgery.

Dr Keisuke Kimura of Kosei Chuo Hospital, Tokyo, Japan and colleagues evaluated the impact of gauge thickness on wound measurement by measuring wound width before and after intraocular lens (IOL) implantation. Subjects were divided into groups with incisions of either 2.2 mm or 2.4 mm, and the team used either a 0.15 mm gauge (F-gauge), which was the same thickness as the knives used during surgery, or a 0.35 mm gauge (A-gauge) to measure the wounds.

The F-gauge measured the 2.2 mm incision wound as 2.20±0.03 mm before IOL implantation, compared with the A-gauge pre-insertion measurement of 2.16±0.05 mm; after insertion of the IOL, the F-gauge measured the wound width as 2.41±0.08 mm, compared with the A-gauge measurement of 2.35±0.09 mm. The F-gauge measured the 2.4 mm incision wound as 2.39±0.04 mm before IOL implantation, compared with the A-gauge pre-insertion measurement of 2.31±0.06 mm. The post-implantation wound width was measured as >2.5 mm for both groups.

The researchers noted that measurement errors increase when the gauge used is thicker than the knife; they concluded that a thicker gauge is less reliable for measuring wound width than is a gauge of equal thickness to the knife.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
© 2025 MJH Life Sciences

All rights reserved.